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Abstract
Glycosylation is a highly complex process to produce a diverse repertoire of cellular glycans that are attached to proteins
and lipids. Glycans are involved in fundamental biological processes, including protein folding and clearance, cell
proliferation and apoptosis, development, immune responses, and pathogenesis. One of the major types of glycans, N-
linked glycans, is formed by sequential attachments of monosaccharides to proteins by a limited number of enzymes. Many
of these enzymes can accept multiple N-linked glycans as substrates, thereby generating a large number of glycan
intermediates and their intermingled pathways. Motivated by the quantitative methods developed in complex network
research, we investigated the large-scale organization of such N-linked glycosylation pathways in mammalian cells. The N-
linked glycosylation pathways are extremely modular, and are composed of cohesive topological modules that directly
branch from a common upstream pathway of glycan synthesis. This unique structural property allows the glycan production
between modules to be controlled by the upstream region. Although the enzymes act on multiple glycan substrates,
indicating cross-talk between modules, the impact of the cross-talk on the module-specific enhancement of glycan
synthesis may be confined within a moderate range by transcription-level control. The findings of the present study provide
experimentally-testable predictions for glycosylation processes, and may be applicable to therapeutic glycoprotein
engineering.
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Introduction
Carbohydrates are a basic cell constituent, and are one of the
most abundant and diverse biopolymers in nature [1]. Complex
carbohydrates have recently become widely recognized as more
than just a metabolic energy source [2–6]. For example, the cell
surface contains a layer of complex carbohydrates involved in
signalling roles that are indispensable to multicellular organisms
[2,7]. Glycosylation, the attachment of glycans (oligosaccharides)
to proteins or lipids, is a ubiquitous post-translational modification
that generates an extensive functional capability from a limited set
of genes [8–10]. In contrast to gene and protein sequences, the
glycosylated glycan sequences are not arranged in a simple linear
chain [5]. Several monosaccharides can be placed simultaneously
on a particular monosaccharide, forming branched structures that
provide enormous glycan structural diversity.
Vertebrates, and especially mammals, have evolved a unique
glycan repertoire which is structurally distinct from that of
nonvertebrate organisms [2,8–10]. Mammalian cells are used as
host cell systems for the production of many recombinant
glycoproteins; these systems can synthesize properly folded
proteins with glycans resembling those in human bodies [11,12].
N-Linked and O-linked glycans are the major contributors to the
structure and function of mammalian secretory glycoproteins. N-
Linked glycans are attached to asparagine residues of proteins,
located within the Asn-X-Ser/Thr motif of amino acids, where X
can be any amino acid except proline.
N-Linked glycosylation occurs co-translationally in the endo-
plasmic reticulum (ER) compartment. The addition of an
oligosaccharide to the peptide at an early stage of glycoprotein
synthesis allows the glycan to participate in the folding and quality
control of a newly synthesized protein [13]. Upon successful
folding of the protein and the trimming of some residues in the
glycan, the glycoprotein migrates into the Golgi apparatus.
Processing in the Golgi involves the removal of mannose groups
and the addition of various monosaccharides to the growing
glycan. The removal of the mannose groups is driven by
mannosidases, and the addition of different monosaccharides is
facilitated by specific glycosyltransferases. Thus, N-linked glyco-
sylation pathways comprise consecutive enzymatic steps that rely
on the glycan structures produced by the previous enzyme to
produce the substrate for the next enzyme. The pathways formed
in this process diverge when a glycan is a substrate for multiple
enzymes, or converge when multiple glycan substrates all lead to
the same product. Many glycan intermediates at different loci
along the pathways, not necessarily glycans at the termini, can be
secreted out of the Golgi to the targeted sites where they perform
biological functions, such as mediating cell growth and develop-
PLoS ONE | www.plosone.org 1 October 2009 | Volume 4 | Issue 10 | e7317ment, cell-cell communication, immune recognition/response,
and molecular homeostasis [2,7–10,14].
Recent advances in understanding the generic properties of
complex networks, including various biological, technological, and
social networks [15,16], allow for a quantitative examination of the
organization of N-linked glycosylation pathways. This develop-
ment in network research has been driven largely by the
availability of massive digital records and statistical methods that
permit network data to be collected and analyzed on a scale far
larger than previously possible. The emerging results in complex
network research have led to the realization that, notwithstanding
the importance of individual molecules, cellular phenotype is a
contextual attribute of seamless and quantifiable network patterns
among numerous constituents [17]. Despite the key role of
glycosylation pathways in sustaining many biological functions,
their large-scale properties have not yet been characterized from a
complex network perspective. Understanding the global organi-
zation of complex networks will provide valuable and perhaps
unique topological information, and may also lead to a better
understanding of the dynamical and evolutionary processes of the
networks, as demonstrated in several other biochemical systems,
such as metabolic networks and protein-protein interaction
networks [18–22]. Here, we explore whether the organization of
glycosylation pathways can be elucidated from a complex network
perspective, by investigating the structural and regulatory
properties of N-linked glycosylation pathways in mammalian cells.
Our findings don’t only have the implications in the organizing
principle of cellular glycosylation processes, but also in the
glycoprotein engineering to be applicable for therapeutic purposes.
Results
Topological Properties and Modularity
We constructed N-linked glycan biosynthetic pathways by
incorporating ten typical N-linked glycosylation enzymes in
mammalian cells and their substrate specificities (Table 1; see
also Materials and Methods). These enzymes can accept multiple
N-linked glycans as substrates, and are thus capable of generating a
large number of glycan intermediates. Construction was initiated
from 9-mannose glycan, the common precursor of N-linked
glycans in the Golgi, and followed by biosynthetic steps to produce
mainly complex-type glycans (Figure 1), giving rise to a
glycosylation network composed of 638 glycans and 1499
enzymatic reactions (Figure 2A).
Table 1. Characteristics of enzymes used in network construction.
Enzyme Substrate requirement Catalyzing reaction
ManI Free a1,2-linked mannose Ordered removal of free a1,2-linked mannose (Materials and Methods)
ManII Free a1,3- or a1,6-linked mannose following a1,6-linked mannose Removal of free a1,3- and a1,6-linked mannoses
Free b1,2-linked N-acetylglucosamine following a1,3-linked mannose
No bisecting b1,4-linked N-acetylglucosamine
GnTI Unique structure of 5-mannose glycan just processed by ManI Addition of b1,2-linked N-acetylglucosamine to a1,3-linked mannose
following b1,4-linked mannose
GnTII No extra mannose other than three in the core Addition of b1,2-linked N-acetylglucosamine to a1,6-linked mannose
No b1,2-linked N-acetylglucosamine following a1,6-linked mannose
Free b1,2-linked N-acetylglucosamine following a1,3-linked mannose
No bisecting b1,4-linked N-acetylglucosamine
GnTIII No bisecting b1,4-linked N-acetylglucosamine Addition of bisecting b1,4-linked N-acetylglucosamine
b1,2-linked N-acetylglucosamine following a1,3-linked mannose
No b1,4-linked galactose
GnTIV No b1,4-linked N-acetylglucosamine following a1,3-linked mannose Addition of b1,4-linked N-acetylglucosamine to a1,3-linked mannose
Free b1,2-linked N-acetylglucosamine following a1,3-linked mannose
No bisecting b1,4-linked N-acetylglucosamine
GnTV No b1,6-linked N-acetylglucosamine Addition of b1,6-linked N-acetylglucosamine
Free b1,2-linked N-acetylglucosamine following a1,6-linked mannose
No bisecting b1,4-linked N-acetylglucosamine
FucT No a1,6-linked fucose Addition of a1,6-linked fucose
b1,2-linked N-acetylglucosamine following a1,3-linked mannose
No bisecting b1,4-linked N-acetylglucosamine
No b1,4-linked galactose
GalT Free N-acetylglucosamine following either of a1,3- or a1,6-linked
mannose
Addition of b1,4-linked galactose to free N-acetylglucosamine following
either of a1,3- or a1,6-linked mannose
SiaT Free b1,4-linked galactose Addition of sialic acid to free b1,4-linked galactose
Substrate for each enzyme should fulfill all the required conditions. For the specific description of glycosidic linkages, refer to glycan structures in Figure 1. ManI:
mannosyl-oligosaccharide 1,2-a-mannosidase; ManII: mannosyl-oligosaccharide 1,3-1,6-a-mannosidase; GnTI: a-1,3-mannosyl-glycoprotein 2-b-N-
acetylglucosaminyltransferase; GnTII: a-1,6-mannosyl-glycoprotein 2-b-N-acetylglucosaminyltransferase; GnTIII: b-1,4-mannosyl-glycoprotein 4-b-N-
acetylglucosaminyltransferase; GnTIV: a-1,3-mannosyl-glycoprotein 4-b-N-acetylglucosaminyltransferase; GnTV: a-1,6-mannosyl-glycoprotein 6-b-N-
acetylglucosaminyltransferase; FucT: glycoprotein 6-a-L fucosyltransferase; GalT: b-N-acetylglucosaminylglycopeptide b-1,4-galactosyltransferase; SiaT: b-galactoside a-
2,3/6-sialyltransferase.
doi:10.1371/journal.pone.0007317.t001
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particular glycan in the glycosylation network was assessed by
counting the number of all downstream substrates that could not
be produced in the absence of the given glycan. Following the
terms in complex network research, this might be analogous to
evaluating the avalanche size of a network after perturbing a single
vertex [23–25]. Figure 2B shows that for most glycans (95.8%) the
absence of an individual glycan did not affect any glycan
production or only hindered the production of fewer than three
glycans. On the other hand, the impact of the removal of the few
remaining glycans (4.2%) spread over a wide range, even up to the
damage at the whole system level. These minor, but highly-
impacting glycans tended to be located adjacent to each other,
thereby occupying a single clustered region in the pathways.
Therefore, the clustered region could be easily distinguished from
the other parts of the network, and was termed the central region
(Materials and Methods). The central region consisted of one
connected component of glycans, including the initial input
substrate, and the non-central or peripheral region was bound to
and derived from this central region.
Modular structure. The spectral method developed for
graph partitioning (Materials and Methods) revealed that the
peripheral region comprised 21 tightly-knit subgraphs. These 21
subgraphs or modules are densely connected groups of glycans,
with only sparser connections between groups. Therefore, the
modules tend to be biosynthetically isolated from each other. This
biosynthetically-modular property of the pathways originates from
the substrate specificity of the enzymes considered here, as
described below, rather than from simple differences in individual
glycan structures that the conventional scheme for glycan
classification [2] has been based on. Interestingly, each module
in the peripheral region was generated from only a few roots, all of
which belonged to the central region (Figures 2A and S1). In other
words, N-linked glycosylation pathways organized their modular
structure in a highly centralized manner; the central region with a
small number of glycans proliferated directly into all 21 modules in
the peripheral region, thereby forming a star-like structure.
Indeed, direct connections between different peripheral modules
were relatively sparse compared with those between the central
and peripheral regions (Figures S1 and S2). Remarkably, the
glycosylation network had unusually high modularity (Q=0.83)
compared with other biological and non-biological networks [26],
suggesting that glycosylation-specific evolutionary pressure was
required for the development of such a unique network structure.
The number of glycans across modules was unevenly distrib-
uted, with the largest module containing 40-fold more glycans
than the smallest module. The discrete jumps between module
sizes in Figure 2C indicate that the size of each module was due to
the complexity of the terminal glycan structures. Specifically, the
more processed the terminal glycans were with N-acetylglucosa-
mines (GlcNAc) following a1,3- and a1,6-linked mannoses, the
greater the number of glycan species that developed in the
module. This glycan enrichment pattern across modules comes
from the inherent capability of carbohydrates to add branches [5]
to the mannose residues, which exponentially diversifies the glycan
structures.
Enzymatic contribution. To better understand the modular
properties of the glycosylation network, we further investigated the
enzymatic reactions involved in module formation. Reactions from
the central to the peripheral region–entry reactions into the
peripheral modules–were dominated by galactosylation (93.5% of
the reactions; see also Figures 2A and S1). Galactosylation and
concurrent sialylation also dominated the reactions (99.0%)
occurring within the peripheral modules (Figure 2A), while the
reactions between these modules mostly comprised GlcNAc addition
(Figure S2). On the other hand, in the central region, all enzymes
except galactosyltransferase (GalT) and sialyltransferase (SiaT)
were involved in the reactions (Figure 2A).
These findings suggest the enzymatic mechanisms that are
responsible for generating the unique modular structure of the
glycosylation network, as highlighted by the role of GalT: GalT
are generous in their substrate specificity, accepting any substrate
with free GlcNAc on the mannose branches, and multiple
products arise from the same substrate depending on the specific
galactosylated residues. Once glycans are galactosylated, however,
they inhibit the approach of many other enzymes (Table 1). Such
tolerance in substrate specificity and product formation facilitates
the development of redundant pathways within each module,
whereas the inhibition of other enzyme activities keeps different
modules separated. The effect of such inhibition for module
differentiation was also observed from another enzyme, b-1,
4-mannosyl-glycoprotein 4-b-N-acetylglucosaminyltransferase
(GnTIII). GnTIII adds bisecting GlcNAc to its substrate, and
the presence of bisecting GlcNAc inhibits the activity of many
enzymes (Table 1). Therefore, the bisecting GlcNAc is thought to
insulate relevant modules, as shown in Figure S2 where the
junctions of different modules only contain glycans without
bisecting GlcNAc. Accordingly, if we exclude the glycan syntheses
catalyzed by GnTIII, then the network becomes slightly less
modular (Q=0.72) as the well-insulated modules selectively
disappear. We believe that this organizing principle of modular
structures manifested by GalT as well as by GnTIII offers a useful
Figure 1. Glycan structures considered in network construction. 9-Mannose glycan enters the N-linked glycan biosynthetic pathways as the
starting substrate (left), and can be processed into a fully sialylated complex-type glycan (right). Symbols indicate the sugar residues according to the
CFG nomenclature [45]. GlcNAc: N-acetylglucosamine; Man: mannose; Fuc: fucose; Gal: galactose; NeuAc: sialic acid.
doi:10.1371/journal.pone.0007317.g001
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PLoS ONE | www.plosone.org 3 October 2009 | Volume 4 | Issue 10 | e7317Figure 2. Modular organization of N-linked glycosylation pathways. (A) The global topology of the constructed N-linked glycosylation
pathways. Circles stand for glycan species and arrows for enzymatic reactions from substrates to products. The size of each circle represents the
impact on the pathways in the absence of the corresponding glycan. Circles and arrows are colored according to the positions in the pathways and
the catalyzing enzymes, respectively. We depict the structures of some early and terminal glycans using the symbols in Figure 1. Glycan synthetic
modules are labelled in the ascending order of the number of the participating glycans. (B) In the absence of each glycan, the number of
extinguished downstream glycans is shown on the horizontal axis, and the vertical axis shows the number of such absent glycans leading to the same
effect. The criterion of the central region is indicated by the arrow at the horizontal axis (Materials and Methods). (C) The number of glycans
participating in each module. Module indices on the horizontal axis follow those appearing in (A). At the top in the horizontal direction, we show the
number of GlcNAc on mannose branches that each terminal glycan has in a corresponding module.
doi:10.1371/journal.pone.0007317.g002
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discussed below.
Regulatory Properties and Cross-Talk
The highly modularized, yet centralized organization of N-
linked glycosylation pathways raises the question of how cells
enhance or suppress the glycan production across modules against
distinct physiological conditions. Within the same module, glycans
are easily convertible to other glycans along densely connected
pathways, whereas the conversion of glycans between different
modules, which are only sparsely connected, is more difficult.
Furthermore, glycans in the peripheral modules are surrounded by
homogeneous enzymatic reactions (catalyzed mostly by GalT and
SiaT in the Golgi), and are thus not as likely to be regulated but
routed randomly along the pathways. Glycans along such
unregulated routes are thought to be trapped for a long time in
a particular module because there are few paths through which
they can enter the other modules [27]; therefore, glycans delivered
from the central region might continue to be processed inside the
arrival modules until they are eventually secreted out of the Golgi.
In this regard, the paths glycans take through the central region
ahead of the peripheral modules likely play a critical role in the end-
product formation.
Specific reactions in the central region may be manipulated by
the transcriptional regulation of enzyme expression. Previous
experiments demonstrated a correlation between glycan produc-
tion and transcript expression of the corresponding enzymes. For
example, the abundance of bisected glycoforms and of GnTIII
transcript as well as that of fucosylated glycoforms and of
glycoprotein 6-a-L fucosyltransferase (FucT) transcript is positive-
ly correlated across different mouse tissues [28–30]. The
heterogeneous enzyme pools in the central region favor such
specific transcriptional control. Glycosylation enzymes, however,
are usually involved in multiple reactions; a change in the
abundance of a single enzyme is likely to affect more than one
reaction in the central region, and a number of modules derived
from the affected reactions will also be affected. Therefore, it is
important to assess specifically how to control these modules that
share the common upstream enzymes to result in the cross-talk
between the modules.
We considered combinations of up- and down-regulation of
glycosylation enzymes that would unambiguously predict changes in
glycan syntheses, and for each case, we determined which modules
would enhance or suppress glycan production relative to their basal
levels (Materials and Methods). Figure 3A shows one such result in
which the down-regulation of GnTIII, a-1,3-mannosyl-glycoprotein
4-b-N-acetylglucosaminyltransferase (GnTIV), and FucT led to the
enhancement of the 1st and 16th modules, but also to the suppression
of the other modules. Minimizing cross-talk or unwanted enhance-
ment of modules other than those specified requires an orchestrated
regulation across enzymes. Under the regulation to minimize such
cross-talk, Figures 3B and 3C show that each enhancement of three-
quarters of the modules was accompanied by the unwanted
enhancement of less than one-third of the modules, and the
enhancement of the remaining modules could be at most
accompanied by the unwanted enhancement of less than one-half
of the modules. Consequently, although the cross-talk between
modules is not negligible, the effect on glycan synthesis is confined
within a moderate range, and probably further reduced by post-
transcriptional regulation or by other combinations of enzyme
regulation which were excluded here for clarity.
The explicit prediction of modules to be enhanced under given
transcriptional regulation (Table S1) can be tested experimen-
tally by measuring the change in the glycan production after
genetic manipulation and identifying the relevant modules. For
example, the production of glycans belonging to the 1st and 16th
modules (Figure S1) is supposed to be increased after gene
knockdown of GnTIII, GnTIV, and FucT, as indicated in
Figure3A. It should benotedthattheglycanproductionherewas
quantified by the amount of flux into the glycan synthesis, rather
than by the glycan abundance itself. Therefore, measuring only
the abundance of secreted glycans and not the abundance of all
the glycan intermediates will be more relevant in this case.
Experimental validation of this prediction will allow us to design
genetic regulation to enhance glycan synthesis in targeted
modules. For example, if some modules contain desirable
glycoproducts like biopharmaceuticals, then genetic regulation
can be applied to enhance the glycan synthesis in these modules,
and accordingly, to increase the production rate of the
biopharmaceutical glycans. Such genetic regulation toward
specific module enhancement might also be applied to reduce
the heterogeneity of glycoforms and to improve the consistencyof
glycoprotein production [11,12].
Figure 3. Regulation of glycan synthesis. (A) Enhancement of
glycan production in specific modul e si si l l u s t r a t e dw i t hap a r to ft h e
pathways in Figure 2(A). The down-regulation of GnTIII, GnTIV, and
FucT weakens the reactions crossed by red lines, thus strengthening
the other reactions toward the 1st and 16th modules, as highlighted.
(B) The modules to be enhanced or suppressed under combinations
of enzyme up- and down-regulation. Here we show only the cases
where six or fewer modules become enhanced, and exclude the
indices of the modules that are never enhanced in these cases. Each
row displays a unique pattern of module enhancement resulting
from certain regulatory combinations, and is labelled as shown in
Table S1. Enhanced modules are colored blue or green, and
suppressed ones are indicated in white. The row including greens
isfor thecasedemonstrated in(A).(C) From the lists ofmodules tobe
enhanced together with a given module on the horizontal axis, we
enumerated the minimum number of such co-enhanced modules as
shown in the vertical axis. Blue is for less than or equal to 6 in the
minimum number, obtained from the module enhancement pattern
s h o w ni n( B ) .
doi:10.1371/journal.pone.0007317.g003
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The complexity and biological significance of protein glycosyl-
ation have long been underestimated, and now, in the post-genomic
era, are at the forefront of scientific research. It is increasingly
appreciated that biological systems exploit glycosylation in synthe-
sizing cell-surface glycans to organize plasma membrane receptors
and control the recruitment of intracellular signal transduction
mediators.Hence, furtherknowledgeofglycobiology will contribute
to deciphering a myriad of biological phenomena. Clearly, a
systems-level understanding of glycosylation processes will advance
such scientific achievement. The N-linked glycosylation pathways
comprise very distinct topological modules, all directly stemming
from the common upstream pathway termed the central region.
This central region might act as a ‘control tower’ of glycan
production by redistributing glycan synthesis fluxes over the
modules to adapt to different physiological conditions. Cross-
activation or cross-talk between the modules, however, will restrict
the fine-tuning level of the flux distribution. The topological
properties of such N-linked glycosylation pathways were elucidated
from a complex network viewpoint that further helps set the
hypotheses on implicated functional and evolutionary properties.
The underlying mechanism of module development is clarified
by the role of GalT, which accepts a wide range of substrates and
makes multiple products to inhibit many other enzyme activities.
The tolerance in glycan synthesis and the inhibition of other
enzyme activities contribute to module formation and differenti-
ation, respectively, while the latter is also observed similarly in the
case of GnTIII. The significant influence of GalT in pathway
formation provides a pattern for the design of novel glycosyltrans-
ferases to implant another module that does not severely disturb
the pre-existing pathways. Such construction or evolution of a new
module would not significantly hamper the functioning of the old
modules, and are thus favorable both for engineering purposes and
for evolution, which could be facilitated [31] by this module-level
modification. Specifically, the sugar residues attached by these
novel enzymes should not inhibit galactosylation and sialylation.
On the other hand, the enzymes should not accept already-
galactosylated substrates. If these two rules are satisfied, then the
enzymes will synthesize glycans at the central region introducing a
new module in the peripheral region. Interestingly, GnTIII
satisfies both rules, and this might be one reason why GnTIII
works properly in recombinant Chinese Hamster Ovary (CHO)
cells although it is not present in wild-type CHO [32–35]. In
addition, CHO cells transfected with GnTIII are utilized in
industry for the production of antibodies that significantly improve
antibody-dependent cellular cytotoxicity and treat neuroblastoma
and non-Hodgkin’s lymphoma [34,35].
More immediate applications for glycoprotein engineering
might arise from the relationship between transcriptional regula-
tion and glycan production, as described above. Orchestrated
regulation of enzyme expression in the central region will allow
glycan production to be enhanced in specific modules, while
avoiding moderately the increased production of other unwanted
modules. Possible deviations between the prediction and the
empirical data may arise due to incompleteness in modelling or
regulation at a post-transcriptional level of which the potential
effects on glycosylation remain largely unknown. Further integra-
tion of poly-N-acetyllactosamine structures and many degradation
mechanisms will dress up the pathways considered here, and the
original pathways can be viewed as an organizational kernel [36]
of which the main properties we expect to be still reflected in more
complicated pathways. Various techniques used to study metabolic
flux analysis are also expected to allow for in-depth analysis of
glycosylation processes [6]. In conjunction with such mathematical
modelling [6,37,38], the development of high-throughput exper-
imental techniques for glycan and glyco-gene profiling [3–5,10]
will further facilitate the systems analysis of glycosylation processes
as successfully demonstrated in this study.
Materials and Methods
Network Construction
N-linked glycosylation pathways were constructed by enumer-
ating N-linked glycan structures commonly observed in mamma-
lian cells [39], starting from the input substrate shown in Figure 1,
which results from an oligosaccharide precursor in the ER with
three glucose residues trimmed out. In our attempts to build
consecutive enzymatic steps, we used ten enzymes constituting a
large proportion of the mammalian N-linked glycosylation
processes. The mannosidases (ManI and ManII) are exoglycosi-
dases that remove mannose groups from N-linked glycans. The
other eight enzymes are glycosyltransferases that catalyze the
formation of glycosidic bonds. Five N-acetylglucosaminyltrans-
ferases (GnTI, GnTII, GnTIII, GnTIV, and GnTV) were
considered for the addition of GlcNAc, and FucT, GalT, and
SiaT for the addition of fucose, galactose, and sialic acid,
respectively.
Based on previous in vivo observations, the removal of a1,2-
linked mannoses by ManI was considered in the following order
[40,41]: ER resident ManI removes free a1,2-linked mannose
attached to a1,3-linked mannose in the initial input substrate and
then Golgi resident ManI removes each of two remaining free
a1,2-linked mannoses successively, making 6-mannose and then 5-
mannose glycans. For the remaining enzymatic reactions, we
applied the substrate specificity data shown in Table 1 obtained
from publicly available literatures [37,42,43]. Except GnTI which
uses only one substrate, the other enzymes could catalyze reactions
that involve the same glycosidic linkage on a range of different
substrates. Finally, by taking into account only the pathways to be
terminated at glycans containing mannoses no more than three in
the core residue, we integrated pathways to produce mainly
complex-type glycans for clarity of analysis. The resulting
pathways are represented by a directional graph in which the
vertices stand for glycan species and the edges for glycan synthetic
reactions with arrows pointing from substrates to products.
Network Decomposition into Subunits
The essentiality of individual glycans in the pathways was
investigated by perturbing the pathways through the removal of
single glycans. For each removal, we calculated how many glycans
could not be produced due to the complete absence of their
substrate production. The removal for most of the glycans gave
only negligible effects (smaller than the cut-off in Figure 2B), and
accordingly, we grouped the remaining glycans, whose removal
had large effects, into those in the central region together with the
early glycans processed by ManI. Glycans in the central region
were located adjacent to each other, forming a self-jointed
subgraph and containing root vertices linked to the non-central
or peripheral region. Different criteria for the central region did
not affect the main results presented here as long as the cut-off was
set between 2,8 (Figure 2B).
The peripheral region could be further partitioned by
maximizing modularity Q for directional graphs [44]:
Q~
1
m
X
ij
Aij{
kin
i kout
j
m
"#
dci,cj,
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otherwise 0. ki
in and kj
out are the numbers of incoming and
outgoing edges of the vertices, m is the total number of edges in
the graph, dij is the Kronecker delta symbol, and ci is the label of
the partition to which vertex i is assigned. Search for the
division of the graph into partitions {ci} maximizing Q is known
to be NP-complete, thus we used the spectral optimization
method [44], which is both computationally efficient and
practically acceptable in terms of partitioning results. For this
purpose, we pre-assigned the central region a partition and
recursively decomposed the peripheral region based on the
spectral method (Q=0.83). The resulting partitions or modules
in the peripheral region were labelled in ascending order of the
number of constituent glycans. The results of such partitioning
on the glycosylation pathways remained robust when an
alternative method that was designed for bidirectional or
undirected graphs was applied by ignoring the edge directions
[26]. Automatic decomposition of all the pathways, including
the central region, yielded only a slight increase in modularity
(DQ=0.02), and this result was excluded to prevent method-
specific over-partitioning that does not convey any information
of biological significance.
Glycan Synthesis Regulation
To evaluate the effect of transcriptional regulation on glycan
synthesis, each enzyme i was assigned variable Ei depending on its
regulated state: Ei=1 if up-regulated, Ei=0 if neutral, and Ei=21
if down-regulated. In addition, let Gij be 1 if enzyme i is involved in
synthesizing glycan j and, otherwise 0. Likewise, Mjk is 1 if glycan j
is located at the entry of module k and, otherwise 0. To focus on
unambiguous cases in the prediction of regulatory effects, we only
considered the combinations of Eis that satisfied the following rules
simultaneously:
(1) Ei ? Ei’$0 for every pair of i and i9 satisfying Gij=Gi’j=1,
when the given j and k satisfy Mjk=1. Hence, the mixture of
both up- and down-regulated enzymes to synthesize a
particular glycan at the entry of any given module was
excluded.
(2)
P
i
EiGij
  
: P
i
EiGij0
  
§0 for every pair of j and j9
satisfying Mjk=Mj9k=1 with a given k. Hence, the mixture
of both enhanced and suppressed glycan production at the
entry of a particular module was excluded.
Furthermore, we kept EManI=ESiaT=0 and EGalT$0 to avoid
an otherwise global and unspecific impact on glycan synthesis
across modules. Each module k could be assigned
Wk~H
P
i,j
EiGijMjk
 !
where H(x)=1, 0, or 21i fx.0, x=0,
or x,0, respectively. Although Wk can be 1, 0, or 21, these three
numbers did not appear simultaneously for any combination of
Eis. For example, some particular combination of Eis allowed Wks
to take 1 and 0, but never observed was a combination allowing
them to take all of 1, 0, and 21. Here we considered the cases
where two of 1, 0, and 21 were taken by Wks for given Eis. Because
we were interested in the regulatory cases keeping a similar level of
the influx of the starting substrate for which modules compete with
each other, modules assigned Wk larger than the other were
expected to have enhanced glycan production relative to their
basal levels, and were otherwise suppressed. (Table S1). For
example, modules assigned Wk=1 were regarded as enhanced
while the others assigned Wk=0 were regarded as suppressed. One
can easily prove that such a regulatory effect remains invariant to
applying both EiR2Ei and permutations of enhanced and
suppressed modules. We also examined alternative regulatory
models, such as explicitly considering the substrate competition
between reactions, but the results did not differ much from the
present results.
Supporting Information
Table S1 Lists of enhanced or suppressed modules under
combinations of enzyme regulation. For the comparison with
Figure 3(B), the most right column labels each regulatory outcome
in which no more than six modules become enhanced.
Found at: doi:10.1371/journal.pone.0007317.s001 (0.09 MB
PDF)
Figure S1 Entry and terminal glycans of peripheral modules.
For each module, the parent glycans in the central region and the
corresponding reactions are also depicted. The bulk of each
module is dominated by galactosylation and sialylation.
Found at: doi:10.1371/journal.pone.0007317.s002 (0.10 MB
PDF)
Figure S2 Reactions between glycans belonging to different
modules.
Found at: doi:10.1371/journal.pone.0007317.s003 (0.08 MB
PDF)
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